MEDP

SEC source: 0001567619-19-021861 · doc1.xml · derivative · entry 3

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,301

Underlying: Common Stock · 518 shares

Expires 2021-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable.

SEC source: 0001567619-19-021861 · doc1.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,760,584

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001567619-19-021861 · doc1.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,760,029

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001567619-19-020079 · doc1.xml · derivative · entry 1

King Tom C · CIK 0001792446 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,021

Underlying: Common Stock · 3,021 shares

Expires 2026-10-24

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001567619-19-019867 · doc1.xml · nonDerivative · entry 1

EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2019.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $76.71 to $77.83. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001567619-19-019630 · doc1.xml · nonDerivative · entry 2

GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,348

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2019.

SEC source: 0001567619-19-019630 · doc1.xml · nonDerivative · entry 1

GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,948

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2019.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $78.00 to $78.96. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001567619-19-018796 · doc1.xml · derivative · entry 8

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 71,414

Underlying: Common Stock · 1,851 shares

Expires 2022-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-018796 · doc1.xml · derivative · entry 7

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 14,813

Underlying: Common Stock · 2,222 shares

Expires 2021-07-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-018796 · doc1.xml · derivative · entry 6

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 112,819

Underlying: Common Stock · 4,313 shares

Expires 2021-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-018796 · doc1.xml · nonDerivative · entry 4

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 7,759,511

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-018796 · doc1.xml · nonDerivative · entry 3

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 7,757,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-018796 · doc1.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 7,755,438

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-018793 · doc1.xml · derivative · entry 6

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,414

Underlying: Common Stock · 1,851 shares

Expires 2022-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable.

SEC source: 0001567619-19-018793 · doc1.xml · derivative · entry 5

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,813

Underlying: Common Stock · 2,222 shares

Expires 2021-07-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable.

SEC source: 0001567619-19-018793 · doc1.xml · derivative · entry 4

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,819

Underlying: Common Stock · 4,313 shares

Expires 2021-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable.

SEC source: 0001567619-19-018793 · doc1.xml · nonDerivative · entry 3

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,759,511

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001567619-19-018793 · doc1.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,757,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001567619-19-018793 · doc1.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,755,438

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001567619-19-021858 · doc1.xml · derivative · entry 4

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,414

Underlying: Common Stock · 1,851 shares

Expires 2022-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Correction due to administrative error.

F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable.

SEC source: 0001567619-19-021858 · doc1.xml · derivative · entry 3

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,813

Underlying: Common Stock · 2,222 shares

Expires 2021-07-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Correction due to administrative error.

F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable.

SEC source: 0001567619-19-021858 · doc1.xml · derivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,819

Underlying: Common Stock · 4,313 shares

Expires 2021-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Correction due to administrative error.

F2 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable.

SEC source: 0001567619-19-021854 · doc1.xml · derivative · entry 6

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 71,414

Underlying: Common Stock · 1,851 shares

Expires 2022-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Correction due to administrative error.

F3 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-021854 · doc1.xml · derivative · entry 5

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 14,813

Underlying: Common Stock · 2,222 shares

Expires 2021-07-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Correction due to administrative error.

F3 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-021854 · doc1.xml · derivative · entry 4

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 112,819

Underlying: Common Stock · 4,313 shares

Expires 2021-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Correction due to administrative error.

F3 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-018435 · doc1.xml · derivative · entry 6

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,112

Underlying: Common Stock · 11,112 shares

Expires 2023-03-31

F1 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F2 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable.

F1 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

SEC source: 0001567619-19-018435 · doc1.xml · derivative · entry 5

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,887

Underlying: Common Stock · 10,887 shares

Expires 2022-07-31

F1 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F2 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable.

F1 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

SEC source: 0001567619-19-018435 · doc1.xml · derivative · entry 4

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,265

Underlying: Common Stock · 73,265 shares

Expires 2022-03-31

F1 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F2 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable.

F1 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

SEC source: 0001567619-19-018435 · doc1.xml · derivative · entry 3

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,035

Underlying: Common Stock · 17,035 shares

Expires 2021-07-07

F1 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F2 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable.

F1 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

SEC source: 0001567619-19-018435 · doc1.xml · derivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,132

Underlying: Common Stock · 117,132 shares

Expires 2021-06-10

F1 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F2 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable.

F1 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

SEC source: 0001567619-19-018439 · doc1.xml · derivative · entry 8

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 11,112

Underlying: Common Stock · 11,112 shares

Expires 2023-03-31

F2 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F3 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable.

F2 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-018439 · doc1.xml · derivative · entry 7

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 10,887

Underlying: Common Stock · 10,887 shares

Expires 2022-07-31

F2 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F3 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable.

F2 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-018439 · doc1.xml · derivative · entry 6

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 73,265

Underlying: Common Stock · 73,265 shares

Expires 2022-03-31

F2 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F3 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable.

F2 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-018439 · doc1.xml · derivative · entry 5

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 17,035

Underlying: Common Stock · 17,035 shares

Expires 2021-07-07

F2 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F3 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable.

F2 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-018439 · doc1.xml · derivative · entry 4

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 117,132

Underlying: Common Stock · 117,132 shares

Expires 2021-06-10

F2 · shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F3 · derivative.exercise_date: The stock options subject to this purchase are fully vested and exercisable.

F2 · derivative.underlying_shares: Stock options were purchased pursuant to the Tender Offer Statement on Schedule TO (the "Offer") filed with the Securities and Exchange Commission on August 5, 2019 (together with any subsequent amendments or supplements thereto). Pursuant to the Offer, MPI purchased 229,431 vested stock options from Eligible Holders (as defined in the Offer) upon the terms and conditions set forth in the Offer. The Offer expired at 11:59 p.m., Eastern Time, on September 13, 2019.

F1 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001567619-19-015938 · doc1.xml · derivative · entry 2

EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2024-08-05

F1 · derivative.exercise_date: The option vests immediately upon issuance.

SEC source: 0001567619-19-015941 · doc1.xml · derivative · entry 2

GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2024-08-05

F1 · derivative.exercise_date: The option vests immediately upon issuance.

SEC source: 0001567619-19-015936 · doc1.xml · derivative · entry 4

Troendle August J. · CIK 0001622058 · Director · President & CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2024-08-05

F2 · derivative.exercise_date: The option vests immediately upon issuance.

SEC source: 0001567619-19-015934 · doc1.xml · derivative · entry 2

BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2024-08-05

F1 · derivative.exercise_date: The option vests immediately upon issuance.

SEC source: 0001567619-19-011792 · doc1.xml · derivative · entry 2

DAVENPORT FRED B JR · CIK 0001181154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,472

Underlying: Common Stock · 6,472 shares

Expires 2026-05-17

F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001567619-19-011790 · doc1.xml · derivative · entry 1

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,472

Underlying: Common Stock · 6,472 shares

Expires 2026-05-17

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001567619-19-011796 · doc1.xml · derivative · entry 1

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,472

Underlying: Common Stock · 6,472 shares

Expires 2026-05-17

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001567619-19-011800 · doc1.xml · derivative · entry 1

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,472

Underlying: Common Stock · 6,472 shares

Expires 2026-05-17

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001567619-19-011788 · doc1.xml · derivative · entry 2

Brown Bruce · CIK 0001436840 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,472

Underlying: Common Stock · 6,472 shares

Expires 2026-05-17

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001567619-19-011785 · doc1.xml · derivative · entry 1

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,472

Underlying: Common Stock · 6,472 shares

Expires 2026-05-17

F1 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.

SEC source: 0001567619-19-010146 · doc1.xml · derivative · entry 5

Brown Bruce · CIK 0001436840 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,782 shares

Expires 2024-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option was granted on May 19, 2017. The option was scheduled to vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. The option vested in full on May 17, 2018.

SEC source: 0001567619-19-010146 · doc1.xml · derivative · entry 4

Brown Bruce · CIK 0001436840 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires 2023-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option was granted on November 1, 2016. One-twelfth (1/12th) of the option vested on November 1, 2016. Thereafter, one-twelfth (1/12th) of the option was scheduled to vest on the first day of each calendar month, subject to continued service on the board of directors of the Issuer through such dates. On July 27, 2017, the board of directors of the Issuer voted to accelerate the vesting of the option with the option vesting in full on May 19, 2017.

SEC source: 0001567619-19-010146 · doc1.xml · nonDerivative · entry 3

Brown Bruce · CIK 0001436840 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,295

F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.29 to $58.325. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001567619-19-010146 · doc1.xml · nonDerivative · entry 2

Brown Bruce · CIK 0001436840 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,282

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001567619-19-010146 · doc1.xml · nonDerivative · entry 1

Brown Bruce · CIK 0001436840 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.